09:10 AM EDT, 06/05/2024 (MT Newswires) -- Health care stocks were steady premarket Wednesday with the Health Care Select Sector SPDR Fund ( XLV ) 0.3% higher and the iShares Biotechnology ETF ( IBB ) recently inactive.

Vir Biotechnology ( VIR ) was over 13% higher after saying preliminary data from a mid-stage trial evaluating its investigational hepatitis therapies tobevibart and elebsiran showed sustained virologic response from the two drugs, suggesting potential efficacy.

Mind Medicine (MNMD) declined by nearly 10% after advisers to the US Food and Drug Administration voted against Lykos Therapeutics' psychedelic drug.

Annexon ( ANNX ) was 1.3% lower after it launched an underwritten public offering of $125 million in common shares.